title: Neuroleptic malignant syndrome after addition of paroxetine to olanzapine.
authors: Vassilis P
authors: VP
authors: Kontaxakis
authors: Beata J
authors: BJ
authors: Havaki-Kontaxaki
authors: Dimitra A
authors: DA
authors: Pappa
authors: Dimosthenis E
authors: DE
authors: Katritsis
authors: George N
authors: GN
authors: Christodoulou
mesh_terms: D001569:Benzodiazepines / Q000008:administration & dosage / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D017374:Paroxetine / Q000008:administration & dosage / Q000009:adverse effects*; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D001569:Benzodiazepines; D000077152:Olanzapine; D017374:Paroxetine; D017367:Selective Serotonin Reuptake Inhibitors